Close
ACHEMA MIDDLE EAST 2026

‘Report on key opportunities for advancing clinical trials today’

AI Summary

Hi,

In our latest clinical quarterly report, we are examining some of the key opportunities for where innovative approaches to data and technology can improve and enhance clinical trials, with the help of senior clinical leaders from Pfizer, ICON and Medidata.

Find out more about site-less / direct-to-patient clinical trials, paperless trials and measuring tangible outcomes of patient-centricity by downloading ‘Trends in Data and Tech’

Best regards,

Caitlin Champion

Global Project Director
eyeforpharma
caitlin@eyeforpharma.com
+ 44 (0) 207 375 7190

 

{unsubscribe}Unsubscribe here{/unsubscribe} from this list or update subscription preferences

Senior pharmaceutical decision - makers don’t consume every piece of content. They have sources they trust. Pharma Advancement is one of them.

Reaching this audience means appearing where they already are — inside trusted editorial that covers the full pharmaceutical and life sciences value chain. Our 2026 Media Pack shows you where to be seen:

Magazine & Digital

Where pharmaceutical decision - makers go to understand what’s coming next. Your brand belongs in that conversation.

Insights & Reports

The analysis and research the sector references when it matters most. Being part of it positions you differently.

Brand Authority

The companies that show up consistently in trusted editorial don’t need to explain who they are. They already are.

SUBSCRIBE OUR NEWSLETTER

WHITE PAPERS

RELATED ARTICLES